| Literature DB >> 27262948 |
Grzegorz Czerwonka1, Anna Guzy2, Klaudia Kałuża2, Michalina Grosicka3, Magdalena Dańczuk4, Łukasz Lechowicz2, Dawid Gmiter2, Paweł Kowalczyk5, Wiesław Kaca2.
Abstract
Biofilms formed by Proteus mirabilis strains are a serious medical problem, especially in the case of urinary tract infections. Early stages of biofilm formation, such as reversible and irreversible adhesion, are essential for bacteria to form biofilm and avoid eradication by antibiotic therapy. Adhesion to solid surfaces is a complex process where numerous factors play a role, where hydrophobic and electrostatic interactions with solid surface seem to be substantial. Cell surface hydrophobicity and electrokinetic potential of bacterial cells depend on their surface composition and structure, where lipopolysaccharide, in Gram-negative bacteria, is prevailing. Our studies focused on clinical and laboratory P. mirabilis strains, where laboratory strains have determined LPS structures. Adherence and biofilm formation tests revealed significant differences between strains adhered in early stages of biofilm formation. Amounts of formed biofilm were expressed by the absorption of crystal violet. Higher biofilm amounts were formed by the strains with more negative values of zeta potential. In contrast, high cell surface hydrophobicity correlated with low biofilm amount.Entities:
Keywords: Biofilm; Cell surface hydrophobicity (CSH); Electrokinetic potential; Epifluorescence microscopy; Microbial adherence to hydrocarbons (MATH); Proteus mirabilis
Mesh:
Year: 2016 PMID: 27262948 PMCID: PMC5040740 DOI: 10.1007/s00203-016-1249-x
Source DB: PubMed Journal: Arch Microbiol ISSN: 0302-8933 Impact factor: 2.552
Proteus mirabilis carbohydrate structures
Fig. 1Values of the CSH (%) of Proteus mirabilis strains. Bacterial suspension-to-p-xylene ratio equal to 1:0.25
Fig. 2Values of zeta potential of selected Proteus mirabilis strains
Fig. 3Adherence to hydrophobic and hydrophilic surface of selected strains of Proteus mirabilis in second hour of incubation at 37 °C. a, b S1959 (O3); c, d—PrK 34/57 (O18); e, f PrK 61/57 (O17); g, h K670; i, j K1784 (O18); k, l K2058. Representative images are presented
Fig. 4Biofilm formation by clinical and laboratory strains of Proteus mirabilis expressed as the absorbance of crystal violet at λ = 595 nm. Standard deviation is presented as error bars. One-way ANOVA test showed significant differences (p < 0.05) in presented results with exception of two cases denoted with horizontal line and asterisk mark
Fig. 5Comparison (a) and heatmap (b) of selected features: biofilm amounts (ABS), CSH (%) zeta potential (mV) and growth rate (ABS) of clinical and laboratory strains of Proteus mirabilis. Biofilm values and growth ratio were multiplied by 100 in order to facilitate reading of the graph